Endologix Inc (ELGX.OQ)

ELGX.OQ on NASDAQ Stock Exchange Global Select Market

11 Jul 2014
Price Change (% chg)

$0.17 (+1.19%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ELGX.OQ


Endologix, Inc. (Endologix) is engaged in developing, manufacturing, marketing and selling medical devices for the treatment of aortic disorders. The Company’s principal product is a stent graft and delivery system (ELG System), for the treatment of abdominal aortic aneurysms (AAA) through endovascular repair (EVAR). Its ELG... (more)


Beta: 1.05
Market Cap (Mil.): $926.92
Shares Outstanding (Mil.): 64.01
Dividend: --
Yield (%): --


  ELGX.OQ Industry Sector
P/E (TTM): -- 29.89 35.77
EPS (TTM): -0.03 -- --
ROI: -0.83 9.72 18.27
ROE: -1.44 11.50 19.16
Search Stocks

Medical device maker Endologix's shares slump on weak sales forecast

Feb 28 - Shares of medical device maker Endologix Inc fell as much as 28 percent after the company forecast its slowest annual revenue growth in a decade for 2014, hurt by weak sales in the United States.

28 Feb 2014

MARKET PULSE-Jos A Bank, Mattel, PepsiCo, Sotheby's, Endologix

U.S. stock index futures were little changed on Friday. Dow Jones industrial average futures were down 0.04 percent at 16,266, S&P 500 futures were down 0.13 percent at 1,851.5 and Nasdaq 100 futures were down 0.09 percent at 3,698.

28 Feb 2014


Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: S&P Capital IQ Quantitative Report
Provider: Pechala's Reports
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks